Hanker AB, Brown BP, Meiler J, Marin A, et al. Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity. Cancer Cell 2021;39:1099-1114.
PMID: 34171264